(Q48792993)

15 February 2018

title

The effect of fluticasone propionate on functional status and sleep in children with asthma and on the quality of life of their parents. (English)

1 reference

15 February 2018

0 references

1 reference

fluticasone propionate

1 reference

Mahajan P

1

1 reference

15 February 2018

Pearlman D

series ordinal

2

1 reference

15 February 2018

Okamoto L

series ordinal

3

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

15 February 2018

number of pages

5

1 reference

The Journal of Allergy and Clinical Immunology

inferred from page(s)

published in

1 reference

15 February 2018

volume

102

1 reference

15 February 2018

page(s)

19-23

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

Trends in activity-limiting chronic conditions among children.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970050-8

7 January 2021

Parental perceptions of childhood illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970050-8

7 January 2021

Quality-of-life factors for parents of children with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970050-8

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970050-8

7 January 2021

Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970050-8

7 January 2021

Functional status II(R). A measure of child health status.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970050-8

7 January 2021

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970050-8

7 January 2021

Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970050-8

7 January 2021

Measuring quality of life in the parents of children with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970050-8

7 January 2021

Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970050-8

7 January 2021

Impact of fluticasone propionate powder on health-related quality of life in patients with moderate asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970050-8

7 January 2021

Children and adult perceptions of childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970050-8

7 January 2021

10.1016/S0091-6749(98)70050-8

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

9679843

1 reference

15 February 2018